BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+45.07%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$815M
AUM Growth
+$815M
(+29%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 52.11% |
| 2 | Consumer Staples | 33.56% |
| 3 | Industrials | 5.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
STAAR Surgical
STAA
$1.36B
| $337M | 38.65% | 10,855,179 | – | – |
|
2
Monster Beverage
MNST
$60.9B
| $274M | 31.41% | 4,773,708 | – | – |
|
3
iShares Russell 2000 ETF
IWM
$67B
| $68.8M | 7.9% | 420,000 | – | – |
|
4
Lineage Cell Therapeutics
LCTX
$267M
| $61.7M | 7.09% | 29,971,561 | – | – |
|
5
Axon Enterprise
AXON
$58.7B
| $48M | 5.51% | 760,062 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $19.3M | 2.22% | 7,564,934 | – | – |
|
|
AST
7
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $7.14M | 0.82% | 5,292,156 | – | – |
|
8
Delta Air Lines
DAL
$40.3B
| – | – | 0 | – | – |
|